Renal Osteodystrophy in Chronic Renal Failure

Sprague, 2000, The role of bone biopsy in the diagnosis of renal osteodystrophy, Seminars in Dialysis, 13, 152, 10.1046/j.1525-139x.2000.00042.x Malluche, 1976, Bone histology in incipient and advanced renal failure, Kidney Int, 9, 355, 10.1038/ki.1976.42 Levey, 2002, Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification, Am J Kidney Dis, 39, S46 Bricker, 1972, On the pathogenesis of the uremic state, An exposition of the trade off hypothesis. N Eng J Med, 286, 1093 Wilson, 1985, Altered divalent ion metabolism in early renal failure: Role of 1,25(OH)2D, Kidney Int, 27, 565, 10.1038/ki.1985.48 Fukuda, 1993, Decreased 1,25 dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients, J Clin Invest, 92, 1436, 10.1172/JCI116720 Gogusev, 1997, Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism, Kidney Int, 51, 328, 10.1038/ki.1997.41 Hruska, 1995, Mechanisms of disease: Renal osteodystrophy, N Eng J Med, 333, 1666, 10.1056/NEJM199507203330307 Sherrard, 1993, The spectrum of bone disease in end-stage renal failure: an evolving disorder, Kidney Int, 43, 436, 10.1038/ki.1993.64 Torres, 1995, Bone disease in predialysis, hemodialysis and CAPD patients: Evidence of a better bone response to PTH, Kidney Int, 47, 1434, 10.1038/ki.1995.201 Fukagawa, 2001, Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases, Am J Kidney Dis, 38, S152, 10.1053/ajkd.2001.27426 Wang, 1995, Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity, Am J Kidney Dis, 26, 836, 10.1016/0272-6386(95)90453-0 Coburn, 1980, Renal osteodystrophy, Kidney Int, 17, 677, 10.1038/ki.1980.79 Cundy, 1985, Who gets renal bone disease before beginning dialysis?, British Med J, 290, 271, 10.1136/bmj.290.6464.271 Tsukamoto, 1995, Effect of administering calcium carbonate to treat secondary hyperparathyroidism in non-dialyzed patients with chronic renal failure, Am J Kidney Dis, 25, 879, 10.1016/0272-6386(95)90570-7 Rix, 1999, Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure, Kidney Int, 56, 1084, 10.1046/j.1523-1755.1999.00617.x Qi, 1995, Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis, Am J Kidney Dis, 26, 622, 10.1016/0272-6386(95)90599-5 Quarles, 1992, Intact parathyroid hormone overestimates the presence and severity of parathyroid mediated osseous abnormalities in uremia, J Clin Endocrin Metab, 75, 145 Malluche, 1994, The role of bone biopsy in the management of patients with renal osteodystrophy, J Am Soc Neph, 4, 1631, 10.1681/ASN.V491631 Urena, 1996, Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients, J Am Soc Nephrol, 7, 506, 10.1681/ASN.V73506 Urena, 1999, Circulating biochemical markers of bone remodeling in uremic patients, Kidney Int, 55, 2141, 10.1046/j.1523-1755.1999.00461.x Coen, 1992, Procollagen type I C-terminal extension peptide in predialysis chronic renal failure, Am J Nephrol, 12, 246, 10.1159/000168453 Hamdy, 1995, Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure, Brit Med J, 310, 358, 10.1136/bmj.310.6976.358 Bianci, 1995, Bone status in different degrees of chronic renal failure, Bone, 13, 225, 10.1016/8756-3282(92)90201-7 Stein, 1996, Prevalence and risk factors for osteopenia in dialysis patients, Am J Kidney Dis, 28, 515, 10.1016/S0272-6386(96)90461-8 Moe, 1993, Maintenance of Bone Mass in Patients Receiving Dialytic Therapy, Am J Kidney Dis, 22, 300, 10.1016/S0272-6386(12)70322-0 De Vita, 1992, Assessment of renal osteodystrophy in hemodialysis patients, Medicine, 71, 284, 10.1097/00005792-199209000-00003 Portale, 1984, Effect of dietary phosphorus on circulating concentrations of 1,25 dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency, J Clin Invest, 73, 1580, 10.1172/JCI111365 Llach, 1985, On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency, J Clin Endocrinol Metab, 61, 601, 10.1210/jcem-61-4-601 Kates, 1997, Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure, Am J Kidney Dis, 30, 809, 10.1016/S0272-6386(97)90086-X Nordal, 1988, Low dose calcitriol versus placebo in patients with predialysis chronic renal failure, J Clin Endocrin Metab, 67, 929, 10.1210/jcem-67-5-929 Baker, 1989, 1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial, Kidney Int, 35, 661, 10.1038/ki.1989.36 Goodman, 2000, Coronary artery calcification in young adults with end-stage renal disease undergoing dialysis, N Eng J Med, 342, 1478, 10.1056/NEJM200005183422003 Bianci, 1994, Calcitriol and calcium carbonate therapy in early chronic renal failure, Nephrol Dial Transplant, 9, 1595 Przedlacki, 1995, Bone mineral density evaluated by dual energy x-ray absorptiometry after one year treatment with calcitriol started in the predialysis phase of chronic renal failure, Nephron, 69, 433, 10.1159/000188515